We are LOTTE Biologics! A new company, built on 80 years of tradition!
We embody our core values of being Inspired by Science, Embracing Diversity, Fostering Talent, and Connecting Lives. Our mission is to be the most trusted partner in the industry, with high standards of quality and continuous innovation, to reliably deliver benefits for patients worldwide.
We deliver therapies that make a Healthier World!
To help us meet our mission LOTTE Biologics is in need of a Manager, EH&S - Industrial Hygiene and ADC who will be accountable for administering and executing the environmental, industrial hygiene and safety programs associated with the development and manufacture of Antibody Drug Conjugates at the LBA Syracuse Site to achieve compliance with applicable local/federal regulations and result in an environmentally safe workplace, including the reviews of capital renovations and new construction projects. This position must comply with all Security guidelines, Environmental Health and Safety regulations and the current Good Manufacturing Practices required by the job function.
Specific Knowledge, Skills, Abilities, etc:
Physical Demands:
Potential exposure to all hazardous conditions is anticipated since considerable amount of time is spent in site operations. Must be physically able to wear a PAPR for extended periods.
Work Environment:
Potential exposure to all hazardous conditions is anticipated since considerable amount of time is spent in site operations
Travel:
Occasional travel may be required to offsite meetings, training, conferences, seminars, etc.
We believe that women, people of color, veterans and LGBTQ communities must participate in the work we do, so we strongly encourage applications from people with these identities or who are members of underrepresented communities. If this is the work that you want to do in a culture of inclusion and excellence with the goal of making our world to be a healthier place, then please apply today!
LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS entered the biologics CDMO business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, as of January 1, 2023!
The newly established organization aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. With initial operations in 1948 in Japan, LOTTE has grown to become the fifth-largest conglomerate corporation in South Korea. LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT. LOTTE has 30+ global locations across the US, Europe, and Asia.
An Equal Opportunity Employer
We do not discriminate based on race, color, religion, national origin, sex, age, disability, genetic information, or any other status protected by law or regulation. It is our intention that all qualified applicants are given equal opportunity and that selection decisions be based on job-related factors.
Software Powered by iCIMS
www.icims.com